FDA commissioner defends agency's drug approval decisions after wave of backlash
U.S. Food and Drug Administration Commissioner Marty Makary defended his agency's actions in an interview with CNBC, following criticism from various stakeholders. He emphasized the importance of rigorous scientific evaluation for drug approvals.
რეკლამა: Article Inline